Idenix Pharmaceuticals (IDIX)

[DewDiligence]

>…so basically i am agreeing with you 100%, except your reaction to the jan 9th conference specifically i found curious, as your very well founded misgiving re timing of phase III was known (more or less save maybe one quarter) before this conference.<

I don’t like continually moving targets and I think the newly-disclosed delay ought to be evaluated in the context of the 12-15 month cumulative delay. Management’s credibility is at issue here.

A few sell-side analysts have asserted that the NM283 program has no commercial value and will ultimately be dropped. I don’t agree with this view; however, the more times the timeline is incrementally delayed, the more likely it is that these analysts are right.